Celgene, Nokia, GNC Stocks Tanking After Earnings

Nokia stock is on track for its worstday session in five years

Managing Editor
Oct 26, 2017 at 2:49 PM
facebook twitter linkedin

Stocks are higher this afternoon, with all three major U.S. benchmarks boosted by an array of upbeat earnings reports. However, not all of the day's action is to the upside, with biotech Celgene Corporation (NASDAQ:CELG), tech stock Nokia Oyj (NYSE:NOK), and wellness retailer GNC Holdings Inc (NYSE:GNC) all spiraling. Here's a quick look at what's moving shares of CELG, NOK, and GNC.

Celgene Stock Plummets After Dismal Earnings Report

Celgene stock is down 18% to trade at $97.94 -- earlier hitting a new annual low of $95.50, and pacing toward its worst single-day drop in 17 years -- after the biotech cut its profit and sales guidance for 2020, while also reporting weak sales of its flagship drugs Revlimid and Otezla. Plus, Raymond James downgraded the CELG to "market perform" from "strong buy" and Baird slashed its price target to $103 from $136, just days after Guggenheim said to buy the stock.

Options traders have been quick to respond to CELG stock, with 205,346 contracts exchanged -- nine times the average intraday rate, and a new 12-month high. The weekly 10/27 95-strike put is most active, and it looks like there could be a mix of buy- and sell-to-open activity here. Those buying the puts expect Celgene shares to plummet below $95 by expiration at this Friday's close, while those writing the puts expect the strike to hold as a near-term floor.

Nokia Stock On Track for Worst Day in Five Years

Nokia is down 19.7% to trade at $4.86, among the worst stocks on the New York Stock Exchange (NYSE) today. This comes after the telecom company reported earnings well below Wall Street estimates and lowered its guidance for 2018, citing increased competition in China. NOK stock is on track for its worst day in five years, and is currently trading at its lowest point since February.

While the stock is short-sale restricted (SSR) today, short sellers have been ramping up their bearish exposure in recent weeks. Short interest surged 24.9% in the two most recent reporting periods to 29.24 million shares -- the most since mid-April.

Disappointing Earnings Drop GNC Stock

GNC stock is down 12.4% to trade at $7.12 -- also among the worst on the NYSE -- after the nutrition company reported earnings that fell just short of analyst expectations, citing a negative impact from Hurricanes Harvey, Irma, and Maria. GNC stock has now shed 31% year-to-date, amid increasing pressure from short sellers. Although GNC is currently SSR, short interest increased by 6.4% during the last reporting period to 23.65 million shares, which represents a whopping 35% of the stock's total available float.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners